Hyphens Pharma International (SGX:1J5) EV-to-EBIT : 5.71 (As of May. 22, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Hyphens Pharma International's Enterprise Value is S$62.6 Mil. Hyphens Pharma International's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was S$11.0 Mil. Therefore, Hyphens Pharma International's EV-to-EBIT for today is 5.71.

The historical rank and industry rank for Hyphens Pharma International's EV-to-EBIT or its related term are showing as below:

SGX:1J5' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.62 Med: 7.42 Max: 18.28
Current: 5.71

During the past 8 years, the highest EV-to-EBIT of Hyphens Pharma International was 18.28. The lowest was 3.62. And the median was 7.42.

SGX:1J5's EV-to-EBIT is ranked better than
90.38% of 426 companies
in the Healthcare Providers & Services industry
Industry Median: 18.045 vs SGX:1J5: 5.71

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Hyphens Pharma International's Enterprise Value for the quarter that ended in Jun. 2023 was S$59.5 Mil. Hyphens Pharma International's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was S$11.0 Mil. Hyphens Pharma International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 18.45%.

Hyphens Pharma International EV-to-EBIT Historical Data

The historical data trend for Hyphens Pharma International's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International EV-to-EBIT Chart

Hyphens Pharma International Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-EBIT

Get a 7-Day Free Trial

5.70

4.98

10.19

9.74

5.08

Hyphens Pharma International Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EV-to-EBIT	Get a 7-Day Free Trial										35.86	9.74	-	5.08	-

Competitive Comparison of Hyphens Pharma International's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, Hyphens Pharma International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hyphens Pharma International's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hyphens Pharma International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hyphens Pharma International's EV-to-EBIT falls into.

Hyphens Pharma International EV-to-EBIT Calculation

Hyphens Pharma International's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	62.611	/	10.974
	=	5.71

Hyphens Pharma International's current Enterprise Value is S$62.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hyphens Pharma International's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was S$11.0 Mil.

Hyphens Pharma International (SGX:1J5) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Hyphens Pharma International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 )	=	EBIT	/	Enterprise Value (Q: Jun. 2023 )
	=	10.974	/	59.48944
	=	18.45 %

Hyphens Pharma International's Enterprise Value for the quarter that ended in Jun. 2023 was S$59.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hyphens Pharma International's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was S$11.0 Mil.

Hyphens Pharma International EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyphens Pharma International (SGX:1J5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Tai Seng Street, Level 4, Singapore, SGP, 534138

Website

https://www.hyphensgroup.com

Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International (SGX:1J5) Headlines

No Headlines